Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET.
Yang WangYasutaka FushimiYoshiki ArakawaYoichi ShimizuKohei SanoAkihiko SakataSatoshi NakajimaSachi OkuchiTakuya HinodaSonoko OshimaSayo OtaniTakayoshi IshimoriMasahiro TanjiYohei MineharuKazumichi YoshidaYuji NakamotoPublished in: Japanese journal of radiology (2023)
F-FMISO and ADC might provide a valuable tool for differentiating between IDH mutation status of 2021 WHO classification grade 3 and 4 adult-type diffuse gliomas.